Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7507078rdf:typepubmed:Citationlld:pubmed
pubmed-article:7507078lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C0439660lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C1334095lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C1953345lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C1520767lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C0123258lld:lifeskim
pubmed-article:7507078lifeskim:mentionsumls-concept:C0024779lld:lifeskim
pubmed-article:7507078pubmed:issue2lld:pubmed
pubmed-article:7507078pubmed:dateCreated1994-2-22lld:pubmed
pubmed-article:7507078pubmed:abstractTextThe gene for insulin-like growth factor-binding protein 4 (IGFBP4) codes for a serum protein that binds to the family of insulin-like growth factors and modulates their activity. It has been mapped by in situ hybridization to chromosome region 17q12-q21.1. We have developed a CA-repeat polymorphism from a cosmid clone containing IGFBP4. By linkage analysis, IGFBP4 maps to the chromosome 17q interval THRA1-D17S579. This interval also contains the gene for hereditary breast-ovarian cancer, BRCA1. Genetic recombination between IGFBP4 and BRCA1 places IGFBP4 centromeric to the cancer susceptibility gene and effectively excludes it as a candidate gene for BRCA1. IGFBP4 is, however, one of the closest known centromeric markers for BRCA1; the estimated recombination fraction is 0.015. IGFBP4 and D17S579 together define a 2.8-cM interval that contains BRCA1.lld:pubmed
pubmed-article:7507078pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507078pubmed:languageenglld:pubmed
pubmed-article:7507078pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507078pubmed:citationSubsetIMlld:pubmed
pubmed-article:7507078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507078pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507078pubmed:statusMEDLINElld:pubmed
pubmed-article:7507078pubmed:monthNovlld:pubmed
pubmed-article:7507078pubmed:issn0888-7543lld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:LenoirGGlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:FeunteunJJlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:LynchHHlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:MorganKKlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:PollakMMlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:HuynhHHlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:EhrenborgEElld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:ToninPPlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:VivierAAlld:pubmed
pubmed-article:7507078pubmed:authorpubmed-author:ZazzoBBlld:pubmed
pubmed-article:7507078pubmed:issnTypePrintlld:pubmed
pubmed-article:7507078pubmed:volume18lld:pubmed
pubmed-article:7507078pubmed:geneSymbolIGFBP4lld:pubmed
pubmed-article:7507078pubmed:ownerNLMlld:pubmed
pubmed-article:7507078pubmed:authorsCompleteNlld:pubmed
pubmed-article:7507078pubmed:pagination414-7lld:pubmed
pubmed-article:7507078pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:meshHeadingpubmed-meshheading:7507078-...lld:pubmed
pubmed-article:7507078pubmed:year1993lld:pubmed
pubmed-article:7507078pubmed:articleTitleThe human insulin-like growth factor-binding protein 4 gene maps to chromosome region 17q12-q21.1 and is close to the gene for hereditary breast-ovarian cancer.lld:pubmed
pubmed-article:7507078pubmed:affiliationDepartment of Medicine, McGill University, Montreal, Canada.lld:pubmed
pubmed-article:7507078pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7507078pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:7507078pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3487entrezgene:pubmedpubmed-article:7507078lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507078lld:pubmed